Complete view
Knowledge Check

Knowledge check

Ten multiple-choice questions covering the full Get Site Ready track. Submit to see correct answers and a short rationale for each. This is a self-assessment — results are not stored or transmitted.

Question 1 of 10

Which type of RAM license is required to administer Ac-225 to human patients in the United States?

Question 2 of 10

Standard pancake Geiger-Mueller probes used for Lu-177 surveys are sufficient for Ac-225 contamination monitoring.

Question 3 of 10

The dominant driver of external gamma dose to staff during Ac-225 dose preparation is:

Question 4 of 10

Decay-in-storage hold time for Ac-225 waste should be sized to:

Question 5 of 10

Which role is most often under-trained on a new targeted alpha therapy program?

Question 6 of 10

An Authorized User (AU) for Ac-225 therapy is most commonly named on the license via:

Question 7 of 10

Which control element is most important for managing daughter-gamma dose at the L-block during dose draw?

Question 8 of 10

Under 10 CFR §35.92, decay-in-storage release requires that:

Question 9 of 10

The minimum facility footprint for an outpatient Ac-225 program typically includes:

Question 10 of 10

Patient-release instructions for Ac-225 should be: